On the academic side, Dr. Cohen’s studies in IBD include investigations of both standard and experimental pharmacological therapies, including novel immunomodulatory agents, as well as studies analyzing quality of life and the economics involved in the diagnosis and treatment of IBD.
Dr. Cohen earned his medical degree from Mount Sinai School of Medicine in New York City and completed his residency at Harvard University in Boston. He completed his fellowship in gastroenterology and nutrition at the University of Chicago.
More articles on GI & endoscopy:
5 GI physicians in the news — April 8, 2016
Marriage increases likelihood of screening colonoscopy in men — 5 points
Indomethacin holds no benefit for patients undergoing endoscopic retrograde cholangiopancreatography — 3 points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
